- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01468753
Pilot Study: Acceptability, Feasibility and Efficacy of Vaginal Insemination in HIV Discordant Couples (Female Positive, Male Negative) Desiring Conception in Kisumu, Kenya
May 13, 2015 updated by: University of California, San Francisco
To evaluate the acceptability, feasibility, and efficacy of vaginal insemination as a method of conception in HIV discordant couples (female positive, male negative) desiring pregnancy in Kisumu, Kenya
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In sub-Saharan Africa, HIV is predominantly transmitted via discordant sexual relationships.
With the availability of antiretroviral (ARV) medications, individuals infected with HIV can live relatively normal productive lives.
Societal and cultural expectations as well as personal reproductive intentions drive HIV positive women in discordant relationships to conceive.
Approximately 50% of HIV infected couples desire children.
However, a safe and effective method of conception that minimizes the risk of sexual HIV transmission in HIV discordant couples with a positive woman and negative man has yet to be examined.
To date, published studies have evaluated assisted reproductive methods in HIV discordant couples with a positive man to decrease the risk of HIV transmission.
The investigators intend to evaluate the acceptability, feasibility and efficacy of vaginal insemination with semen for conception in HIV discordant (female positive, male negative) relationships in Kenya.
In this pilot study, HIV discordant couples (female positive, male negative) desiring pregnancy will receive targeted reproductive counseling through the Safer and Healthy Conception Program for 6 months.
This program will emphasize the consistent use of male condoms and teach couples assisted vaginal insemination for conception to minimize the risk of sexual HIV transmission.The investigators will compare the frequency of male condom use before and after intervention with an audio computer-assisted self-interview validated by random measurement of prostate specific antigen of vaginal secretions.
The incidence of pregnancy following vaginal insemination will also be measured.
The investigators hypothesize that our findings will provide evidence to support the routine use of vaginal insemination as a safe method of conception in HIV discordant couples (female positive, male negative).
This pilot study is of significant public health importance because the use of vaginal insemination for conception in HIV discordant couples (female positive, male negative) is expected to reduce the likelihood of riskier sexual practices for childbearing and decrease the incidence of HIV in Sub-Saharan Africa.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kisumu, Kenya
- Family AIDS Care and Education Services - Lumumba Health Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 34 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- HIV discordant couple (female positive, male negative) desiring conception, monogamous relationship (minimum of three month duration), disclosure of HIV status to the sexual partner, women 18-34 years of age, sexually active (at least three encounters per month), expressed ability to consistently use male condoms, and follow the study protocol with respect to study visits and use of vaginal insemination.
Exclusion Criteria:
- pregnant (at the time of enrollment or run-in-period), women over 35 years of age (decreased fertility ≥ 35 years of age), self reported history of sterilization or infertility by either partner, use of teratogenic medication (e.g. Efavirenz), and clinical stage of HIV/AIDS 3 or 4.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vaginal Insemination
Women will perform vaginal insemination during the fertile period of the menstrual cycle with the collected semen within one hour of collection.
Vaginal insemination will occur within one hour of collection 2 days prior to ovulation, on the day of ovulation and 2 days after ovulation for up to 6 months or until conception occurs.
For example, if ovulation were on day 14 of a 28 day menstrual cycle, vaginal insemination will occur on days 12, 14 and 16 of the cycle.
|
Women will perform vaginal insemination during the fertile period with semen within one hour of collection.
Vaginal insemination will occur within one hour of collection 2 days prior to ovulation, on the day of ovulation and 2 days after ovulation for up to 6 months or until conception occurs.
For example, if ovulation were on day 14 of a 28 day menstrual cycle, vaginal insemination will occur on days 12, 14 and 16 of the cycle.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To evaluate the feasibility of vaginal insemination in HIV discordant couples as compared to natural conception.
Time Frame: 8 months
|
8 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To evaluate the consistent use of male condoms for the prevention of sexual transmission of HIV.
Time Frame: 8 months
|
8 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Director: Betty Njoroge, MB. ChB, MPH, Kenya Medical Research Institute
- Study Chair: Craig Cohen, MD, MPH, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (Actual)
February 1, 2014
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
November 7, 2011
First Submitted That Met QC Criteria
November 8, 2011
First Posted (Estimate)
November 9, 2011
Study Record Updates
Last Update Posted (Estimate)
May 15, 2015
Last Update Submitted That Met QC Criteria
May 13, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P30 AIO27763
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Discordant Couples
-
Case Comprehensive Cancer CenterNot yet recruiting
-
Rune Zahl-OlsenCompleted
-
Midwest Evaluation & ResearchThe RIDGE ProjectRecruiting
-
Andalusian Initiative for Advanced Therapies -...Iniciativa Andaluza en Terapias AvanzadasCompletedDiscordant Immunological Response in HIV Infected SubjectsSpain
-
NYU Langone HealthNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
Universitat Oberta de CatalunyaNot yet recruitingCouples | Relational Problems
-
University of Colorado, DenverNational Cancer Institute (NCI)CompletedCouples | Cancer DiagnosisUnited States
-
University of Texas at AustinDepartment of Health and Human ServicesRecruiting
-
Freie Universität BerlinDeutsche Krebshilfe e.V., Bonn (Germany)CompletedPhysical Activity | Health Behavior | CouplesGermany
-
University of MichiganUniversity of Miami; University of RochesterCompleted
Clinical Trials on Vaginal Insemination
-
EndoCeutics Inc.CompletedHypoactive Sexual Desire DisorderUnited States, Canada
-
HaEmek Medical Center, IsraelTerminated
-
Medical University of ViennaReproductive Sciences Ltd.UnknownInseminationAustria, France, Germany, United Kingdom
-
University Hospital, GasthuisbergCompleted
-
Baskent UniversityCompleted
-
Universitas PadjadjaranCompleted
-
Pamukkale UniversityCompleted
-
HaEmek Medical Center, IsraelCompleted
-
CHU de Quebec-Universite LavalRecruiting
-
IVI BilbaoCompletedEndometriosis I-II